Skip to Main Content
Table 1—

Demographic and clinical characteristics of participants by sex

Female subjectsMale subjects
n (%) 1,034 (49.4) 1,059 (50.6) 
Age (years) 14.5 ± 2.1 14.5 ± 2.0 
Diabetes duration (years) 6.3 ± 3.6 5.8 ± 3.4 
BMI (kg/m222.8 ± 12.6 21.7 ± 3.7 
Insulin dose (units · kg−1 · day−11.0 ± 0.3 1.0 ± 0.3 
Hypoglycemic episodes (last 3 months/100 patient-years) 27 ± 170 24 ± 114 
DKA (last 12 months/100 patient-years) 4 ± 21 4 ± 30 
A1C (%) (n = 2,036) 8.3 ± 1.5 8.1 ± 1.3 
Different insulin regimens   
    Miscellaneous 141 (13.6) 168 (15.9) 
    Twice-daily premix 77 (7.4) 83 (7.8) 
    Twice-daily free mix 128 (12.4) 168 (15.9) 
    Thrice daily 26 (2.5) 42 (4.0) 
    Basal bolus 487 (47.1) 439 (41.5) 
    CSII 175 (16.9) 159 (15.0) 
Concomitant problems   
    Celiac disease 45 (4.4) 36 (3.4) 
    Thyroid disease 94 (9.1) 29 (2.7) 
    Epilepsy 5 (0.5) 14 (1.3) 
    Asthma 26 (2.5) 35 (3.3) 
    Other 53 (5.1) 48 (4.5) 
Female subjectsMale subjects
n (%) 1,034 (49.4) 1,059 (50.6) 
Age (years) 14.5 ± 2.1 14.5 ± 2.0 
Diabetes duration (years) 6.3 ± 3.6 5.8 ± 3.4 
BMI (kg/m222.8 ± 12.6 21.7 ± 3.7 
Insulin dose (units · kg−1 · day−11.0 ± 0.3 1.0 ± 0.3 
Hypoglycemic episodes (last 3 months/100 patient-years) 27 ± 170 24 ± 114 
DKA (last 12 months/100 patient-years) 4 ± 21 4 ± 30 
A1C (%) (n = 2,036) 8.3 ± 1.5 8.1 ± 1.3 
Different insulin regimens   
    Miscellaneous 141 (13.6) 168 (15.9) 
    Twice-daily premix 77 (7.4) 83 (7.8) 
    Twice-daily free mix 128 (12.4) 168 (15.9) 
    Thrice daily 26 (2.5) 42 (4.0) 
    Basal bolus 487 (47.1) 439 (41.5) 
    CSII 175 (16.9) 159 (15.0) 
Concomitant problems   
    Celiac disease 45 (4.4) 36 (3.4) 
    Thyroid disease 94 (9.1) 29 (2.7) 
    Epilepsy 5 (0.5) 14 (1.3) 
    Asthma 26 (2.5) 35 (3.3) 
    Other 53 (5.1) 48 (4.5) 

Data are means ± SD or n (%).

Close Modal

or Create an Account

Close Modal
Close Modal